Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy

Eila Monteagudo-Gimeno; R. Sánchez-González; Joaquim Raduà; Lydia Fortea; Teresa Boget-Llucià; Maria del Mar Carreño Martínez; Antonio Jesús Donaire-Pedraza; Nuria Bargalló; Xavier Setoain; Jordi Rumià-Arboix; Antonio Bulbena; Luis Pintor-Pérez

doi:10.1016/j.heliyon.2023.e20903

Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy

Eila Monteagudo-Gimeno, R. Sánchez-González, Joaquim Raduà, Lydia Fortea, Teresa Boget-Llucià, Maria del Mar Carreño Martínez, Antonio Jesús Donaire-Pedraza, Nuria Bargalló, Xavier Setoain, Jordi Rumià-Arboix, Antonio Bulbena, Luis Pintor-Pérez

Department of Psychiatry and Legal Medicine

Research output: Contribution to journal › Article › Research › peer-review

1 Citation (Scopus)

Abstract

Depressive/anxious disorders and cognitive impairment are frequent comorbidities in epilepsy and have a more deleterious effect in DRE.•Studies concerning the relationship between anxiety and depression and cognitive performance in DRE are scarce.•Higher scores in HADS are associated with lower QOLIE-31 scores and might be considered as predictors of QOL in DRE.•A relationship between anxious and depressive symptoms -measured with HADS and SCL-90R- and cognition might not exist.•There remains an unexplored study area regarding this relationship which requires more attention to improve the assessment of DRE.

Original language	English
Article number	e20903
Number of pages	8
Journal	Heliyon
Volume	9
Issue number	10
DOIs	https://doi.org/10.1016/j.heliyon.2023.e20903
Publication status	Published - Oct 2023

Access to Document

10.1016/j.heliyon.2023.e20903

https://ddd.uab.cat/record/284590

Cite this

Monteagudo-Gimeno, E., Sánchez-González, R., Raduà, J., Fortea, L., Boget-Llucià, T., Carreño Martínez, M. D. M., Donaire-Pedraza, A. J., Bargalló, N., Setoain, X., Rumià-Arboix, J., Bulbena, A., & Pintor-Pérez, L. (2023). Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy. Heliyon, 9(10), Article e20903. https://doi.org/10.1016/j.heliyon.2023.e20903

@article{4c432908228c4193a0dcbe3689a77431,

title = "Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy",

abstract = "Depressive/anxious disorders and cognitive impairment are frequent comorbidities in epilepsy and have a more deleterious effect in DRE.•Studies concerning the relationship between anxiety and depression and cognitive performance in DRE are scarce.•Higher scores in HADS are associated with lower QOLIE-31 scores and might be considered as predictors of QOL in DRE.•A relationship between anxious and depressive symptoms -measured with HADS and SCL-90R- and cognition might not exist.•There remains an unexplored study area regarding this relationship which requires more attention to improve the assessment of DRE.",

author = "Eila Monteagudo-Gimeno and R. S{\'a}nchez-Gonz{\'a}lez and Joaquim Radu{\`a} and Lydia Fortea and Teresa Boget-Lluci{\`a} and {Carre{\~n}o Mart{\'i}nez}, {Maria del Mar} and Donaire-Pedraza, {Antonio Jes{\'u}s} and Nuria Bargall{\'o} and Xavier Setoain and Jordi Rumi{\`a}-Arboix and Antonio Bulbena and Luis Pintor-P{\'e}rez",

note = "{\textcopyright} 2023 The Authors.",

year = "2023",

month = oct,

doi = "10.1016/j.heliyon.2023.e20903",

language = "English",

volume = "9",

journal = "Heliyon",

issn = "2405-8440",

publisher = "Elsevier Ltd",

number = "10",

}

Monteagudo-Gimeno, E, Sánchez-González, R, Raduà, J, Fortea, L, Boget-Llucià, T, Carreño Martínez, MDM, Donaire-Pedraza, AJ, Bargalló, N, Setoain, X, Rumià-Arboix, J, Bulbena, A & Pintor-Pérez, L 2023, 'Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy', Heliyon, vol. 9, no. 10, e20903. https://doi.org/10.1016/j.heliyon.2023.e20903

TY - JOUR

T1 - Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy

AU - Monteagudo-Gimeno, Eila

AU - Sánchez-González, R.

AU - Raduà, Joaquim

AU - Fortea, Lydia

AU - Boget-Llucià, Teresa

AU - Carreño Martínez, Maria del Mar

AU - Donaire-Pedraza, Antonio Jesús

AU - Bargalló, Nuria

AU - Setoain, Xavier

AU - Rumià-Arboix, Jordi

AU - Bulbena, Antonio

AU - Pintor-Pérez, Luis

PY - 2023/10

Y1 - 2023/10

N2 - Depressive/anxious disorders and cognitive impairment are frequent comorbidities in epilepsy and have a more deleterious effect in DRE.•Studies concerning the relationship between anxiety and depression and cognitive performance in DRE are scarce.•Higher scores in HADS are associated with lower QOLIE-31 scores and might be considered as predictors of QOL in DRE.•A relationship between anxious and depressive symptoms -measured with HADS and SCL-90R- and cognition might not exist.•There remains an unexplored study area regarding this relationship which requires more attention to improve the assessment of DRE.

AB - Depressive/anxious disorders and cognitive impairment are frequent comorbidities in epilepsy and have a more deleterious effect in DRE.•Studies concerning the relationship between anxiety and depression and cognitive performance in DRE are scarce.•Higher scores in HADS are associated with lower QOLIE-31 scores and might be considered as predictors of QOL in DRE.•A relationship between anxious and depressive symptoms -measured with HADS and SCL-90R- and cognition might not exist.•There remains an unexplored study area regarding this relationship which requires more attention to improve the assessment of DRE.

UR - http://www.scopus.com/inward/record.url?scp=85174745842&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/d69d6fd6-8a3e-3967-9000-af6d2a5c019e/

U2 - 10.1016/j.heliyon.2023.e20903

DO - 10.1016/j.heliyon.2023.e20903

M3 - Article

C2 - 37886767

SN - 2405-8440

VL - 9

JO - Heliyon

JF - Heliyon

IS - 10

M1 - e20903

ER -

Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy

Abstract

Access to Document

Other files and links

Fingerprint

Cite this